Works matching DE "SODIUM-glucose cotransporters"

Results: 1909

SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance.

Published in:

Cardiovascular Research, 2025, v. 121, n. 4, p. 643, doi. 10.1093/cvr/cvae257

By:

Mroueh, Ali;
Algara-Suarez, Paola;
Fakih, Walaa;
Gong, Dal-Seong;
Matsushita, Kensuke;
Park, Sin-Hee;
Amissi, Said;
Auger, Cyril;
Kauffenstein, Gilles;
Meyer, Nicolas;
Ohlmann, Patrick;
Jesel, Laurence;
Pieper, Michael Paul;
Marchandot, Benjamin;
Morel, Olivier;
Mazzucotelli, Jean-Philippe;
Schini-Kerth, Valérie B

Publication type:

Article

Dihydromyricetin ameliorates hyperuricemia through inhibiting uric acid reabsorption.

Published in:

Journal of the Science of Food & Agriculture, 2025, v. 105, n. 8, p. 4178, doi. 10.1002/jsfa.14126

By:

Sun, Ze‐Rui;
Peng, Hui‐Zhen;
Fan, Mao‐Si;
Chang, Dong;
Wang, Ming‐Yue;
An, Meng‐Fei;
Zhang, Li‐Juan;
Zan, Rui;
Sheng, Jun;
Zhao, Yun‐Li;
Wang, Xuan‐Jun

Publication type:

Article

Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in type 2 diabetes according to baseline glucagon‐like peptide‐1 receptor agonist and sodium‐glucose co‐transporter‐2 inhibitor use: A post hoc analysis of ONWARDS 1–5

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 6, p. 3165, doi. 10.1111/dom.16328

By:

Vilsbøll, Tina;
Fu, Ariel;
Kellerer, Monika;
Kumar, Bharath;
Søgaard, Stinne Byrholdt;
Goldenberg, Ronald

Publication type:

Article

Baseline predictors of genital mycotic infections following sodium-glucose cotransporter-2 inhibitors initiation in men with type 2 diabetes.

Published in:

Indian Journal of Pharmacology, 2023, v. 55, n. 5, p. 338, doi. 10.4103/ijp.ijp_307_23

By:

Banerjee, Mainak;
Mukherjee, Ayan;
Hazra, Avijit;
Mukhopadhyay, Satinath

Publication type:

Article

Impact of sodium-glucose co-transporter 2 inhibitors on renal outcomes in patients of diabetes mellitus: A meta-analysis of landmark renal and cardiovascular outcome trials.

Published in:

Indian Journal of Pharmacology, 2023, v. 55, n. 2, p. 119, doi. 10.4103/ijp.ijp_342_21

By:

Bose, Debdipta;
Maurya, Miteshkumar;
Konwar, Mahanjit

Publication type:

Article

Evaluation of glycemic status among hypercholesterolemic patients on atorvastatin in a tertiary care hospital – A retrospective study.

Published in:

Indian Journal of Pharmacology, 2022, v. 54, n. 3, p. 165, doi. 10.4103/ijp.ijp_943_20

By:

Nalini, R;
Ramya, J;
Karthick, R

Publication type:

Article

Mechanisms and prediction of short-term natriuretic effect of sodium-glucose cotransporter 2 inhibitor in heart failure patients coexisting type 2 diabetes mellitus.

Published in:

Heart & Vessels, 2020, v. 35, n. 9, p. 1218, doi. 10.1007/s00380-020-01597-x

By:

Fukuoka, Shusuke;
Dohi, Kaoru;
Takeuchi, Tetsushiro;
Moriwaki, Keishi;
Ishiyama, Masaki;
Omori, Taku;
Fujimoto, Naoki;
Ito, Masaaki

Publication type:

Article

Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies.

Published in:

Acta Diabetologica, 2024, v. 61, n. 6, p. 755, doi. 10.1007/s00592-024-02252-x

By:

Shi, Yanjing;
Dong, Shujie;
Xu, Yang;
Ji, Dongze;
Yang, Li;
Zhao, Rongsheng

Publication type:

Article

Assessing early tubular protective effects of SGLT2 inhibitor empagliflozin against type 2 diabetes mellitus using functional magnetic resonance imaging.

Published in:

Acta Diabetologica, 2024, v. 61, n. 4, p. 473, doi. 10.1007/s00592-023-02220-x

By:

Zhang, Chuangbiao;
Zhu, Beibei;
Feng, Youzhen;
Cheng, Zhongyuan;
Cai, Xiangran;
Feng, Lie;
Li, Jiaying;
Lu, Xiaohua

Publication type:

Article

Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.

Published in:

Acta Diabetologica, 2023, v. 60, n. 12, p. 1651, doi. 10.1007/s00592-023-02154-4

By:

Diallo, Alhassane;
Carlos-Bolumbu, Miguel;
Galtier, Florence

Publication type:

Article

Diabetic patients with and without sodium-glucose cotransporter-2 inhibitors use and cataract risk: real-world observational investigation.

Published in:

Acta Diabetologica, 2023, v. 60, n. 7, p. 981, doi. 10.1007/s00592-023-02087-y

By:

Hu, Wei-Syun;
Lin, Cheng-Li

Publication type:

Article

Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong.

Published in:

Acta Diabetologica, 2023, v. 60, n. 7, p. 917, doi. 10.1007/s00592-023-02063-6

By:

Mui, Jonathan V.;
Li, Lifang;
Chou, Oscar Hou In;
Azfar, Nida;
Lee, Athena;
Hui, Jeremy;
Lee, Sharen;
Tse, Gary;
Zhou, Jiandong

Publication type:

Article

Effect of sodium–glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis.

Published in:

Acta Diabetologica, 2023, v. 60, n. 2, p. 191, doi. 10.1007/s00592-022-01981-1

By:

Fakhrolmobasheri, Mohammad;
Abhari, Amir Parsa;
Manshaee, Behrad;
Heidarpour, Maryam;
Shafie, Davood;
Mohammadbeigi, Ehsan;
Mozafari, Amir Mohammad;
Mazaheri-Tehrani, Sadegh

Publication type:

Article

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.

Published in:

Acta Diabetologica, 2022, v. 59, n. 4, p. 519, doi. 10.1007/s00592-021-01830-7

By:

Ding, Chen;
Tang, Yaxin;
Zhu, Wenqiang;
Huang, Piaopiao;
Lian, Pingan;
Ran, Juanli;
Huang, Xiansheng

Publication type:

Article

Risk of lower extremity amputations in patients with type 2 diabetes using sodium-glucose co-transporter 2 inhibitors.

Published in:

Acta Diabetologica, 2022, v. 59, n. 2, p. 233, doi. 10.1007/s00592-021-01805-8

By:

Zerovnik, Spela;
Kos, Mitja;
Locatelli, Igor

Publication type:

Article

Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy.

Published in:

Acta Diabetologica, 2021, v. 58, n. 8, p. 1059, doi. 10.1007/s00592-021-01681-2

By:

Castoldi, Giovanna;
Carletti, Raffaella;
Ippolito, Silvia;
Colzani, Massimiliano;
Barzaghi, Francesca;
Stella, Andrea;
Zerbini, Gianpaolo;
Perseghin, Gianluca;
Zatti, Giovanni;
di Gioia, Cira R. T.

Publication type:

Article

Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials.

Published in:

Acta Diabetologica, 2021, v. 58, n. 7, p. 869, doi. 10.1007/s00592-021-01686-x

By:

Rao, Lunwen;
Ren, Chenhong;
Luo, Shan;
Huang, Chenghu;
Li, Xuefeng

Publication type:

Article

Incretin mimetics and sodium-glucose co-transporter 2 inhibitors as monotherapy or add-on to metformin for treatment of type 2 diabetes: a systematic review and network meta-analysis.

Published in:

Acta Diabetologica, 2021, v. 58, n. 1, p. 5, doi. 10.1007/s00592-020-01542-4

By:

Jia, Shubing;
Wang, Zhiying;
Han, Ruobing;
Zhang, Zinv;
Li, Yuping;
Qin, Xiaotong;
Zhao, Mingyi;
Xiang, Rongwu;
Yang, Jingyu

Publication type:

Article

Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study.

Published in:

Acta Diabetologica, 2020, v. 57, n. 10, p. 1181, doi. 10.1007/s00592-020-01533-5

By:

Chen, Yi-Chuan;
Chen, Tien-Hsing;
Sun, Chi-Chin;
Chen, Jau-Yuan;
Chang, Shy-Shin;
Yeung, Ling;
Tsai, Yi-Wen

Publication type:

Article

The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.

Published in:

Acta Diabetologica, 2020, v. 57, n. 10, p. 1129, doi. 10.1007/s00592-020-01529-1

By:

Jin, Yuxin;
Zhao, Hang;
Hou, Yilin;
Song, Guangyao

Publication type:

Article

Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?

Published in:

2020

By:

Patoulias, Dimitrios;
Papadopoulos, Christodoulos;
Doumas, Michael

Publication type:

Letter

Trend 2010–2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy.

Published in:

Acta Diabetologica, 2020, v. 57, n. 3, p. 367, doi. 10.1007/s00592-019-01445-z

By:

Fadini, Gian Paolo;
Frison, Vera;
Rigato, Mauro;
Morieri, Mario Luca;
Simioni, Natalino;
Tadiotto, Federica;
D'Ambrosio, Michele;
Paccagnella, Agostino;
Lapolla, Annunziata;
Avogaro, Angelo

Publication type:

Article

The roots of SGLT inhibition: Laurent-Guillaume de Koninck, Jean Servais Stas and Freiherr Josef von Mering.

Published in:

Acta Diabetologica, 2019, v. 56, n. 1, p. 29, doi. 10.1007/s00592-018-1206-z

By:

Jörgens, Viktor

Publication type:

Article

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials.

Published in:

Acta Diabetologica, 2018, v. 55, n. 5, p. 503, doi. 10.1007/s00592-018-1116-0

By:

Puckrin, Robert;
Saltiel, Marie-Philippe;
Reynier, Pauline;
Azoulay, Laurent;
Yu, Oriana H. Y.;
Filion, Kristian B.

Publication type:

Article

Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.

Published in:

Acta Diabetologica, 2017, v. 54, n. 1, p. 19, doi. 10.1007/s00592-016-0892-7

By:

Monami, Matteo;
Dicembrini, Ilaria;
Mannucci, Edoardo

Publication type:

Article

Erratum to: Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.

Published in:

2017

By:

Monami, Matteo;
Dicembrini, Ilaria;
Mannucci, Edoardo

Publication type:

Erratum

Role of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Published in:

Acta Diabetologica, 2016, v. 53, n. 6, p. 863, doi. 10.1007/s00592-016-0856-y

By:

Solini, Anna

Publication type:

Article

Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats.

Published in:

Journal of Pharmacy & Pharmacology, 2014, v. 66, n. 7, p. 975, doi. 10.1111/jphp.12223

By:

Tahara, Atsuo;
Kurosaki, Eiji;
Yokono, Masanori;
Yamajuku, Daisuke;
Kihara, Rumi;
Hayashizaki, Yuka;
Takasu, Toshiyuki;
Imamura, Masakazu;
Li, Qun;
Tomiyama, Hiroshi;
Kobayashi, Yoshinori;
Noda, Atsushi;
Sasamata, Masao;
Shibasaki, Masayuki

Publication type:

Article

Effect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Published in:

Zagazig University Medical Journal, 2024, v. 30, p. 336, doi. 10.21608/ZUMJ.2024.275740.3237

By:

Elkot, Moataz A.;
Ibrahim, Yasser Gaber;
Refaat, Refaat Mohamed;
Abomandour, Hala Gouda

Publication type:

Article

Flozyny jako jeden z „czterech filarów” terapii niewydolności serca.

Published in:

Heart & Vascular Diseases / Choroby Serca & Naczyn, 2023, v. 20, n. 2/3, p. 92, doi. 10.5603/chsin.97793

By:

Piłat, Patrycja;
Jurkiewicz, Michał;
Krych, Sebastian;
Szyguła-Jurkiewicz, Bożena

Publication type:

Article

Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors.

Published in:

BMC Molecular & Cell Biology, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12860-020-00279-w

By:

Muhammad, Syed Aun;
Ashfaq, Hiba;
Zafar, Sidra;
Munir, Fahad;
Jamshed, Muhammad Babar;
Chen, Jake;
Zhang, Qiyu

Publication type:

Article

Renoprotective Effect of Thai Patients with Type 2 Diabetes Mellitus Treated with SGLT-2 Inhibitors versus DPP-4 Inhibitors: A Real-World Observational Study.

Published in:

Advances in Pharmacological & Pharmaceutical Sciences, 2023, p. 1, doi. 10.1155/2023/5581417

By:

Chanawong, Apichaya;
Uitrakul, Suriyon;
Incomenoy, Supatcha;
Poonchuay, Natnicha

Publication type:

Article

Euglycemic diabetic ketoacidosis associated with empagliflozin in patients hospitalized with acute pulmonary embolism.

Published in:

Clinical Diabetology, 2021, v. 10, n. 2, p. 204, doi. 10.5603/DK.a2021.0010

By:

Wibawa, Kevin;
Kuhuwael, Ferica Valentine;
Julyanto Putra, Caesar Rio;
Utami Widiastuti, Sandra;
Paskah Suciadi, Leonardo

Publication type:

Article

The use of dapagliflozin in the treatment of type 1 diabetes in a 36-year-old patient.

Published in:

Clinical Diabetology, 2021, v. 10, n. 2, p. 200, doi. 10.5603/DK.a2021.0013

By:

Rutkowska, Katarzyna;
Cypryk, Katarzyna

Publication type:

Article

Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor.

Published in:

Journal of the Endocrine Society, 2023, v. 7, n. 4, p. 1, doi. 10.1210/jendso/bvad011

By:

Monnerat, Sophie;
Atila, Cihan;
Refardt, Julie;
Christ-Crain, Mirjam

Publication type:

Article

Erratum to: Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM.

Published in:: 2021
Publication type:: Correction Notice

CORRIGENDUM FOR "Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM".

Published in:: 2020
Publication type:: Correction Notice

Glucoregulatory Properties of Fermented Soybean Products.

Published in:

Fermentation (Basel), 2023, v. 9, n. 3, p. 254, doi. 10.3390/fermentation9030254

By:

Yu, Songfeng;
Wang, Wenjun;
Li, Shanshan;
Li, Jiaheng;
Zhao, Runan;
Liu, Donghong;
Wu, Jianping

Publication type:

Article

GLUCOSE, PROTEIN, CHOLESTEROL AND IMMUNOHAEMATOLOGICAL ALTERATIONS WITH ACUTE (SDS) SODIUM DODECYL SULFATE TOXICITY IN CLARIAS BATRACHUS.

Published in:

Journal of Experimental Zoology India, 2020, v. 23, n. 1, p. 401

By:

Kumar, Ashok;
Yadav, Chandra Bhan;
Bajpeyee, Anand Kumar

Publication type:

Article

Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm?

Published in:

Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484231186855

By:

Giglio, Rosaria Vincenza;
Muzurović, Emir M.;
Patti, Angelo Maria;
Toth, Peter P.;
Agarwal, Manyoo A.;
Almahmeed, Wael;
Klisic, Aleksandra;
Ciaccio, Marcello;
Rizzo, Manfredi

Publication type:

Article

Neuroprotective effect of canagliflozin against cisplatin-induced cerebral cortex injury is mediated by regulation of HO-1/PPAR-γ, SIRT1/FOXO-3, JNK/AP-1, TLR4/iNOS, and Ang II/Ang 1–7 signals.

Published in:

Immunopharmacology & Immunotoxicology, 2023, v. 45, n. 3, p. 304, doi. 10.1080/08923973.2022.2143371

By:

Hassanein, Emad H. M.;
Saleh, Fayez M.;
Ali, Fares E. M.;
Rashwan, Eman K.;
Atwa, Ahmed M.;
Abd El-Ghafar, Omnia A. M.

Publication type:

Article

Effect of Normosil Probiotic Supplementation on the Growth Performance and Blood Parameters of Broiler Chickens.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, n. 4, p. 1046, doi. 10.5530/ijper.54.4.199

By:

Khabirov, Airat;
Khaziakhmetov, Fail;
Kuznetsov, Vyacheslav;
Tagirov, Hamit;
Rebezov, Maksim;
Andreyeva, Aleksandra;
Basharov, Almaz;
Yessimbekov, Zhanibek;
Ayaz, Muhammad

Publication type:

Article

NEW DIRECTIONS IN PHARMACOLOGICAL TREATMENT WITH SGLT-2 INHIBITOR MOLECULES IN THE LIGHT OF CURRENT GUIDELINES FOR DIABETES MELLITUS, HEART FAILURE AND KIDNEY DISEASE.

Published in:

Farmacia, 2023, v. 71, n. 4, p. 686, doi. 10.31925/farmacia.2023.4.4

By:

TILINCA, MARIANA CORNELIA;
ANTAL, CSILLA;
SĂLCUDEAN, ANDREEA;
ABĂLAŞEI, BIANCA LARISA;
FĂRCAŞ, ROXANA MARIA;
GROŞAN, ALEXANDRA

Publication type:

Article

A PARADIGM SHIFT FOR THE SGLT2 INHIBITORS - TREATING THE HEART WITH ANTI-HYPERGLYCAEMIC DRUGS.

Published in:

Farmacia, 2021, v. 69, n. 5, p. 837, doi. 10.31925/farmacia.2021.5.2

By:

BĂDILĂ, ELISABETA;
BALAHURA, ANA-MARIA;
STOIAN, MARILENA;
BARTOȘ, DANIELA;
VINEREANU, DRAGOȘ

Publication type:

Article

Antihyperglycemic Effects of Salvia polystachya Cav. and Its Terpenoids: α-Glucosidase and SGLT1 Inhibitors.

Published in:

Plants (2223-7747), 2022, v. 11, n. 5, p. N.PAG, doi. 10.3390/plants11050575

By:

Ortega, Rocio;
Valdés, Miguel;
Alarcón-Aguilar, Francisco J.;
Fortis-Barrera, Ángeles;
Barbosa, Elizabeth;
Velazquez, Claudia;
Calzada, Fernando

Publication type:

Article

Effect of Insulin on Proximal Tubules Handling of Glucose: A Systematic Review.

Published in:

Journal of Diabetes Research, 2020, p. 1, doi. 10.1155/2020/8492467

By:

Pereira-Moreira, Ricardo;
Muscelli, Elza

Publication type:

Article

How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.

Published in:

Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/2018374

By:

Canivell, Silvia;
Mata-Cases, Manel;
Vlacho, Bogdan;
Gratacòs, Mònica;
Real, Jordi;
Mauricio, Dídac;
Franch-Nadal, Josep

Publication type:

Article

ISPAD Annual Conference 2019 Highlights.

Published in:

2020

By:

Addala, Ananta;
March, Christine;
Marks, Brynn;
Tommerdahl, Kalie;
Shapiro, Jenna;
Oyenusi, Elizabeth;
Yauch, Lauren McClure;
Goethals, Eveline R.;
Ahmad, Peerzada Ovais;
Adhami, Sara;
Ng, May;
Ehtisham, Sarah;
Agwu, Juliana Chizo

Publication type:

Proceeding

ISPAD Clinical Practice Consensus Guidelines 2018: What is new in diabetes care?

Published in:

2018

By:

Codner, Ethel;
Acerini, Carlo L.;
Craig, Maria E.;
Hofer, Sabine E.;
Maahs, David M.

Publication type:

Editorial

ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth.

Published in:

Pediatric Diabetes, 2018, v. 19, p. 28, doi. 10.1111/pedi.12719

By:

Zeitler, Phillip;
Arslanian, Silva;
Fu, Junfen;
Pinhas‐Hamiel, Orit;
Reinehr, Thomas;
Tandon, Nikhil;
Urakami, Tatsuhiko;
Wong, Jencia;
Maahs, David M.

Publication type:

Article